New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Olema Pharmaceuticals, Inc.
OLMA
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

661M

Biotechnology

Next Earning date - 05 Nov 2024

661M

Biotechnology

Next Earning date - 05 Nov 2024

11.55USD
Shape-0.17 ( -1.45%)
favorite-chart

Relative Strenght

89
favorite-chart

Volume Buzz

-48%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

35%

Quote Panel

Shape
Updated October 26, 2024
1W -4.31 % 1M -5.25 % 3M -23.96 % 1Y -11.76 %

Key Metrics

Shape
  • Market Cap

    661.43M


  • Shares Outstanding

    57.27M


  • Share in Float

    49.24M


  • Dividende

    0


  • Earning Date

    05 Nov 2024


  • Price Target

    11.55


  • Average Volume

    537339


  • Beta

    2.034


  • Range

    8.51-17.791


  • Industry

    Biotechnology


  • Website

    https://www.olema.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

351.08x

P/S Ratio

2.86x

P/B Ratio

0.0

Debt/Equity

-5818.8%

Net Margin

$-2.0

EPS

How OLMA compares to sector?

P/E Ratio

Relative Strength

Shape

OLMA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape
0

$2.57

Shape-375%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Goldman Sachs

initialise

Previous: Not converted

2024-04-02

Now: Buy

H.C. Wainwright

upgrade

Previous: Not converted

2022-06-09

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.57
vs -0.45

Q4.22

arrow
arrow

N/A

-0.65
vs -0.54

Q1.23

arrow
arrow

N/A

-0.70
vs -0.58

Q2.23

arrow
arrow

N/A

-0.49
vs -0.82

Q3.23

arrow
arrow

N/A

-0.48
vs -0.57

Q4.23

arrow
arrow

N/A

-0.49
vs -0.65

Q1.24

arrow
arrow

N/A

-0.56
vs -0.70

Q2.24

arrow
arrow

N/A

-0.54
vs -0.49

Q3.24

arrow
arrow

N/A

-0.58
vs -0.48

Q4.24

arrow
arrow

N/A

-0.62
vs -0.49

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

1.9M  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-10%

-0.10
vs -0.14

Q4.22

arrow
arrow

-13%

-0.13
vs -0.10

Q1.23

arrow
arrow

-15%

-0.15
vs -0.13

Q2.23

arrow
arrow

-12%

-0.12
vs -0.15

Q3.23

arrow
arrow

-8%

-0.08
vs -0.12

Q4.23

arrow
arrow

-11%

-0.11
vs -0.08

Q1.24

arrow
arrow

-13%

-0.13
vs -0.11

Q2.24

arrow
arrow

-13%

-0.13
vs -0.13

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

71

71
vs 74

-4%

Q4.22

arrow
arrow

68

68
vs 71

-4%

Q1.23

arrow
arrow

67

67
vs 68

-1%

Q2.23

arrow
arrow

90

90
vs 67

34%

Q3.23

arrow
arrow

105

105
vs 90

17%

Q4.23

arrow
arrow

121

121
vs 105

15%

Q1.24

arrow
arrow

129

129
vs 121

7%

Q2.24

arrow
arrow

129

129
vs 129

NA

Earnings Growth

Latest News